Eminent Chemtech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-07-2024
- Paid Up Capital ₹ 0.10 M
as on 02-07-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.30 M
as on 02-07-2024
- Revenue 87.15%
(FY 2023)
- Profit 40.10%
(FY 2023)
- Ebitda -10.25%
(FY 2023)
- Net Worth 99.90%
(FY 2023)
- Total Assets 52.56%
(FY 2023)
About Eminent Chemtech
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.30 M.
Abhinav Jain and Kapil Jain serve as directors at the Company.
- CIN/LLPIN
U24100DL2019PTC344681
- Company No.
344681
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Eminent Chemtech Private Limited offer?
Eminent Chemtech Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Nail Polish, Nail Cosmetics, Nail Set, Body Powder, Industrial Chemicals & Supplies, Monomer, Costume & Fashion Jewelry, Jewelry Craft.
Who are the key members and board of directors at Eminent Chemtech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhinav Jain  | Director | 18-Jan-2019 | Current |
| Kapil Jain | Director | 18-Jan-2019 | Current |
Financial Performance of Eminent Chemtech.
Eminent Chemtech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 87.15% increase. The company also saw a substantial improvement in profitability, with a 40.1% increase in profit. The company's net worth Soared by an impressive increase of 99.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eminent Chemtech?
In 2023, Eminent Chemtech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Mar 2023 | ₹6.30 M | Open |
How Many Employees Work at Eminent Chemtech?
Eminent Chemtech has a workforce of 32 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eminent Chemtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eminent Chemtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
